Indian patent filing targets next-generation psychedelics for addiction treatment

Indian patent filing targets next-generation psychedelics for addiction treatment

Clearmind Medicine (Nasdaq: CMND) Filed a patent application in India on March 27, 2026 for the next generation, non-hallucinogenic neuroplastogen-derived compounds targeting mental health disorders and addiction. The filing, with the Indian Patent Office, expands the company’s global intellectual property portfolio and forms an exclusive worldwide license agreement with Yissumseeking … Read more

Standard Process targets a market gap with brain supplements for senior dogs

arrow

Standard Process highlights cognitive health as an emerging target for supplements for older dogs, noting that pet owners are increasingly aware of this area of ​​well-being. The brand’s note formulation mirrors that of human brain health supplements, for example, featuring the same functional botanicals and nutrients that people consume for mental clarity, resilience, and behavioral … Read more